IART

Integra Lifesciences Holdings Stock Analysis

AI Rating

Fair
  • Quality2/10
  • Growth↓ 2/10
  • Value↓ 2/10
Integra Lifesciences Holdings sales and earnings growth
IART Growth
Fair
  • Revenue Y/Y↓ 1.53%
  • EPS Y/Y↓ -7388.89%
  • FCF Y/Y↓ -224.39%
Integra Lifesciences Holdings gross and profit margin trends
IART Profitability
Fair
  • Gross margin ↑ 50.90%
  • EPS margin↓ -31.60%
  • ROIC 5Y↓ -0.89%
Integra Lifesciences Holdings net debt vs free cash flow
IART Risk
Good
  • Debt / Equity↓ 1.9
  • Debt / FCF↑ 57.9
  • Interest coverage↓ -5.5

Integra Lifesciences Holdings stock volatility is in-line with the overall market. We give it a Good risk rating.

More Medical Devices stocks ↗